Innovation Pharmaceuticals Inc (IPIX)

[Drano]

There WAS blockbuster news at the conference, to those who understood it.

That said, I do disagree with others here about the presentation. I think the new doc was very low key and did not adequately explain the significance of the spleen tumor almost disappearing, nor did he explain the patient's not continuing in the trial very well. People who are extremely knowledgeable about something often think that others will instantly understand, instead of spelling things out. I think that if he had said, "The great reduction in a metastatic spleen tumor caused by ovarian cancer, after only 6 doses of Kevetrin, is something that is almost unheard of. We regret that the patient made what we believe to be a bad choice on the basis of a 10% increase in one CA-125 test, a test which is notoriously unreliable and which can show increases for reasons that are unrelated to cancer recurring. We had felt that her best chance would have been to continue in further trials of Kevetrin, but we hope that the positive effects from her participation in our trial have helped her, and hope that she will continue to improve."